{"id":17936,"date":"2025-06-10T12:02:35","date_gmt":"2025-06-10T16:02:35","guid":{"rendered":"https:\/\/mdbc2.wpenginepowered.com\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid="},"modified":"2025-06-10T12:02:35","modified_gmt":"2025-06-10T16:02:35","slug":"insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq","status":"publish","type":"product","link":"https:\/\/www.mdbriefcase.com\/fr\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=","title":{"rendered":"Insuline et diab\u00e8te de type 2 \u2013 Prise en charge transform\u00e9e par les nouvelles options th\u00e9rapeutiques &#8211; Ordre des pharmaciens du Qu\u00e9bec (OPQ)"},"content":{"rendered":"<p>Ce programme mettra \u00e0 jour les HCP sur la gestion du T2DM avec des analogues basoliques \u00e0 action prolong\u00e9e et une intensification th\u00e9rapeutique avec des combinaisons d\u2019insuline basale et de RA GLP-1.<\/p>","protected":false},"excerpt":{"rendered":"<p>Ce programme mettra \u00e0 jour les HCP sur la gestion du T2DM avec des analogues basoliques \u00e0 action prolong\u00e9e et une intensification th\u00e9rapeutique avec des combinaisons d\u2019insuline basale et de RA GLP-1.<\/p>","protected":false},"featured_media":0,"comment_status":"","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"product_brand":[],"product_cat":[],"product_tag":[],"class_list":{"0":"post-17936","1":"product","2":"type-product","3":"status-publish","6":"first","7":"instock","8":"downloadable","9":"virtual","10":"taxable","11":"product-type-simple"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Insuline et diab\u00e8te de type 2 \u2013 Prise en charge transform\u00e9e par les nouvelles options th\u00e9rapeutiques - Ordre des pharmaciens du Qu\u00e9bec (OPQ) - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insuline et diab\u00e8te de type 2 \u2013 Prise en charge transform\u00e9e par les nouvelles options th\u00e9rapeutiques - Ordre des pharmaciens du Qu\u00e9bec (OPQ) - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"Ce programme mettra \u00e0 jour les HCP sur la gestion du T2DM avec des analogues basoliques \u00e0 action prolong\u00e9e et une intensification th\u00e9rapeutique avec des combinaisons d\u2019insuline basale et de RA GLP-1.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=\",\"url\":\"https:\/\/www.mdbriefcase.com\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=\",\"name\":\"Insuline et diab\u00e8te de type 2 \u2013 Prise en charge transform\u00e9e par les nouvelles options th\u00e9rapeutiques - Ordre des pharmaciens du Qu\u00e9bec (OPQ) - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"datePublished\":\"2025-06-10T16:02:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop &#8211; Old\",\"item\":\"https:\/\/www.mdbriefcase.com\/shop\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Insuline et diab\u00e8te de type 2 \u2013 Prise en charge transform\u00e9e par les nouvelles options th\u00e9rapeutiques &#8211; Ordre des pharmaciens du Qu\u00e9bec (OPQ)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insuline et diab\u00e8te de type 2 \u2013 Prise en charge transform\u00e9e par les nouvelles options th\u00e9rapeutiques - Ordre des pharmaciens du Qu\u00e9bec (OPQ) - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=","og_locale":"fr_CA","og_type":"article","og_title":"Insuline et diab\u00e8te de type 2 \u2013 Prise en charge transform\u00e9e par les nouvelles options th\u00e9rapeutiques - Ordre des pharmaciens du Qu\u00e9bec (OPQ) - MDBriefCase","og_description":"Ce programme mettra \u00e0 jour les HCP sur la gestion du T2DM avec des analogues basoliques \u00e0 action prolong\u00e9e et une intensification th\u00e9rapeutique avec des combinaisons d\u2019insuline basale et de RA GLP-1.","og_url":"https:\/\/www.mdbriefcase.com\/fr\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=","og_site_name":"MDBriefCase","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=","url":"https:\/\/www.mdbriefcase.com\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=","name":"Insuline et diab\u00e8te de type 2 \u2013 Prise en charge transform\u00e9e par les nouvelles options th\u00e9rapeutiques - Ordre des pharmaciens du Qu\u00e9bec (OPQ) - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"datePublished":"2025-06-10T16:02:35+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid="]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/product\/insuline-et-diabete-de-type-2-prise-en-charge-transformee-par-les-nouvelles-options-therapeutiques-ordre-des-pharmaciens-du-quebec-opq\/?courseid=#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Shop &#8211; Old","item":"https:\/\/www.mdbriefcase.com\/shop\/"},{"@type":"ListItem","position":3,"name":"Insuline et diab\u00e8te de type 2 \u2013 Prise en charge transform\u00e9e par les nouvelles options th\u00e9rapeutiques &#8211; Ordre des pharmaciens du Qu\u00e9bec (OPQ)"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product\/17936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=17936"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=17936"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=17936"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=17936"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=17936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}